September 1, 2026Learning Objectives, Light Therapy, TCPR, September 2026After reading these articles, you should be able to…
September 1, 2026By Chris Aiken, MDFDA Approves Bysanti: Patent Extension Gone WildThe FDA just approved a new antipsychotic for schizophrenia and bipolar mania. Here's what you need to know before you prescribe it.
September 1, 2026By Norman Rosenthal, MDLight Therapy: Beyond Seasonal DepressionLight therapy works faster than antidepressants, helps more patients than you think, and costs nothing to prescribe. Here's how to use it.
September 1, 2026By Jesse Koskey, MD.Pramipexole Shows Consistent Antidepressant Benefits Across Two RCTs, But Side Effects Limit Use
September 1, 2026By Alla Alexander, MDSelegiline Patch May Offer Safer Option for Treatment-resistant Depression
August 1, 2026By Tommy Baumel, MDMirtazapine Helps Older Adults Sleep, but Side Effects Limit Staying Power
August 1, 2026By Rida Fatima, MDDextromethorphan as Early Augmentation for Mild to Moderate Depression
General PsychiatryKarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change EverythingRead More
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024